{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:16:37Z","timestamp":1788869797519,"version":"build-2803163510"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2018,6,7]],"date-time":"2018-06-07T00:00:00Z","timestamp":1528329600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1007\/s00259-018-4068-2","type":"journal-article","created":{"date-parts":[[2018,6,6]],"date-time":"2018-06-06T23:00:56Z","timestamp":1528326056000},"page":"1998-2008","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Prognostic value of myocardial perfusion imaging performed pre-renal transplantation: post-transplantation follow-up and outcomes"],"prefix":"10.1007","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7390-7784","authenticated-orcid":false,"given":"Christopher W.","family":"Ives","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wael A.","family":"AlJaroudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vineeta","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayman","family":"Farag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana V.","family":"Rizk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"Oparil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ami E.","family":"Iskandrian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fadi G.","family":"Hage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,6,7]]},"reference":[{"key":"4068_CR1","volume-title":"2016 USRDS Annual Data Report: Epidemiology of kidney disease in the United States","author":"United States Renal Data System","year":"2016","unstructured":"United States Renal Data System. 2016 USRDS Annual Data Report: Epidemiology of kidney disease in the United States. Bethesda: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2016."},{"key":"4068_CR2","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.jacc.2012.05.008","volume":"60","author":"KL Lentine","year":"2012","unstructured":"Lentine KL, Costa SP, Weir MR, Robb JF, Fleisher LA, Kasiske BL, et al. Cardiac disease evaluation and management among kidney and liver transplantation candidates: a scientific statement from the American Heart Association and the American College of Cardiology Foundation. J Am Coll Cardiol. 2012;60:434\u201380. \n                    https:\/\/doi.org\/10.1016\/j.jacc.2012.05.008\n                    \n                  .","journal-title":"J Am Coll Cardiol"},{"key":"4068_CR3","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1007\/s12350-015-0303-4","volume":"24","author":"R Doukky","year":"2017","unstructured":"Doukky R, Fughhi I, Campagnoli T, Wassouf M, Ali A. The prognostic value of regadenoson SPECT myocardial perfusion imaging in patients with end-stage renal disease. J Nucl Cardiol. 2017;24:112\u20138. \n                    https:\/\/doi.org\/10.1007\/s12350-015-0303-4\n                    \n                  .","journal-title":"J Nucl Cardiol"},{"key":"4068_CR4","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1016\/j.amjcard.2007.04.045","volume":"100","author":"FG Hage","year":"2007","unstructured":"Hage FG, Smalheiser S, Zoghbi GJ, Perry GJ, Deierhoi M, Warnock D, et al. Predictors of survival in patients with end-stage renal disease evaluated for kidney transplantation. Am J Cardiol. 2007;100:1020\u20135. \n                    https:\/\/doi.org\/10.1016\/j.amjcard.2007.04.045\n                    \n                  .","journal-title":"Am J Cardiol"},{"key":"4068_CR5","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1016\/j.amjcard.2008.07.029","volume":"102","author":"R Venkataraman","year":"2008","unstructured":"Venkataraman R, Hage FG, Dorfman T, Heo J, Aqel RA, de Mattos AM, et al. Role of myocardial perfusion imaging in patients with end-stage renal disease undergoing coronary angiography. Am J Cardiol. 2008;102:1451\u20136. \n                    https:\/\/doi.org\/10.1016\/j.amjcard.2008.07.029\n                    \n                  .","journal-title":"Am J Cardiol"},{"key":"4068_CR6","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/S0002-9149(03)00529-0","volume":"92","author":"AD Patel","year":"2003","unstructured":"Patel AD, Abo-Auda WS, Davis JM, Zoghbi GJ, Deierhoi MH, Heo J, et al. Prognostic value of myocardial perfusion imaging in predicting outcome after renal transplantation. Am J Cardiol. 2003;92:146\u201351.","journal-title":"Am J Cardiol"},{"key":"4068_CR7","doi-asserted-by":"publisher","unstructured":"Doukky R, Fughhi I, Campagnoli T, Wassouf M, Kharouta M, Vij A, et al. Validation of a clinical pathway to assess asymptomatic renal transplant candidates using myocardial perfusion imaging. J Nucl Cardiol. 2017. \n                    https:\/\/doi.org\/10.1007\/s12350-017-0901-4\n                    \n                  .","DOI":"10.1007\/s12350-017-0901-4"},{"key":"4068_CR8","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1007\/s12350-015-0234-0","volume":"23","author":"W AlJaroudi","year":"2016","unstructured":"AlJaroudi W, Campagnoli T, Fughhi I, Wassouf M, Ali A, Doukky R. Prognostic value of heart rate response during regadenoson stress myocardial perfusion imaging in patients with end stage renal disease. J Nucl Cardiol. 2016;23:560\u20139. \n                    https:\/\/doi.org\/10.1007\/s12350-015-0234-0\n                    \n                  .","journal-title":"J Nucl Cardiol"},{"key":"4068_CR9","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1007\/s12350-015-0269-2","volume":"23","author":"E Andrikopoulou","year":"2016","unstructured":"Andrikopoulou E, Hage FG. Heart rate response to regadenoson: making the case for its value in clinical practice. J Nucl Cardiol. 2016;23:575\u201380. \n                    https:\/\/doi.org\/10.1007\/s12350-015-0269-2\n                    \n                  .","journal-title":"J Nucl Cardiol"},{"key":"4068_CR10","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.ahj.2011.05.014","volume":"162","author":"FG Hage","year":"2011","unstructured":"Hage FG, Dean P, Bhatia V, Iqbal F, Heo J, Iskandrian AE. The prognostic value of the heart rate response to adenosine in relation to diabetes mellitus and chronic kidney disease. Am Heart J. 2011;162:356\u201362. \n                    https:\/\/doi.org\/10.1016\/j.ahj.2011.05.014\n                    \n                  .","journal-title":"Am Heart J"},{"key":"4068_CR11","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1007\/s12350-011-9429-1","volume":"18","author":"FG Hage","year":"2011","unstructured":"Hage FG, Dean P, Iqbal F, Heo J, Iskandrian AE. A blunted heart rate response to regadenoson is an independent prognostic indicator in patients undergoing myocardial perfusion imaging. J Nucl Cardiol. 2011;18:1086\u201394. \n                    https:\/\/doi.org\/10.1007\/s12350-011-9429-1\n                    \n                  .","journal-title":"J Nucl Cardiol"},{"key":"4068_CR12","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1016\/j.amjcard.2009.01.007","volume":"103","author":"R Venkataraman","year":"2009","unstructured":"Venkataraman R, Hage FG, Dorfman TA, Heo J, Aqel RA, de Mattos AM, et al. Relation between heart rate response to adenosine and mortality in patients with end-stage renal disease. Am J Cardiol. 2009;103:1159\u201364. \n                    https:\/\/doi.org\/10.1016\/j.amjcard.2009.01.007\n                    \n                  .","journal-title":"Am J Cardiol"},{"key":"4068_CR13","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1161\/CIR.0b013e31826e1058","volume":"126","author":"K Thygesen","year":"2012","unstructured":"Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD, et al. Third universal definition of myocardial infarction. Circulation. 2012;126:2020\u201335. \n                    https:\/\/doi.org\/10.1161\/CIR.0b013e31826e1058\n                    \n                  .","journal-title":"Circulation"},{"key":"4068_CR14","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1161\/01.CIR.0000133317.49796.0E","volume":"110","author":"SM Grundy","year":"2004","unstructured":"Grundy SM, Cleeman JI, Merz CN, Brewer HB Jr, Clark LT, Hunninghake DB, et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation. 2004;110:227\u201339. \n                    https:\/\/doi.org\/10.1161\/01.CIR.0000133317.49796.0E\n                    \n                  .","journal-title":"Circulation"},{"key":"4068_CR15","doi-asserted-by":"publisher","first-page":"e80","DOI":"10.1016\/j.nuclcard.2006.08.011","volume":"13","author":"MJ Henzlova","year":"2006","unstructured":"Henzlova MJ, Cerqueira MD, Mahmarian JJ, Yao SS. Stress protocols and tracers. J Nucl Cardiol. 2006;13:e80\u201390. \n                    https:\/\/doi.org\/10.1016\/j.nuclcard.2006.08.011.","journal-title":"J Nucl Cardiol"},{"key":"4068_CR16","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1007\/s12350-014-0050-y","volume":"22","author":"FG Hage","year":"2015","unstructured":"Hage FG, Ghimire G, Lester D, McKay J, Bleich S, El-Hajj S, et al. The prognostic value of regadenoson myocardial perfusion imaging. J Nucl Cardiol. 2015;22:1214\u201321. \n                    https:\/\/doi.org\/10.1007\/s12350-014-0050-y\n                    \n                  .","journal-title":"J Nucl Cardiol"},{"key":"4068_CR17","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.amjcard.2012.09.013","volume":"111","author":"FM Iqbal","year":"2013","unstructured":"Iqbal FM, Al Jaroudi W, Sanam K, Sweeney A, Heo J, Iskandrian AE, et al. Reclassification of cardiovascular risk in patients with normal myocardial perfusion imaging using heart rate response to vasodilator stress. Am J Cardiol. 2013;111:190\u20135. \n                    https:\/\/doi.org\/10.1016\/j.amjcard.2012.09.013\n                    \n                  .","journal-title":"Am J Cardiol"},{"key":"4068_CR18","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.nuclcard.2007.06.006","volume":"14","author":"EP Ficaro","year":"2007","unstructured":"Ficaro EP, Lee BC, Kritzman JN, Corbett JR. Corridor4DM: the Michigan method for quantitative nuclear cardiology. J Nucl Cardiol. 2007;14:455\u201365. \n                    https:\/\/doi.org\/10.1016\/j.nuclcard.2007.06.006\n                    \n                  .","journal-title":"J Nucl Cardiol"},{"key":"4068_CR19","first-page":"2138","volume":"36","author":"G Germano","year":"1995","unstructured":"Germano G, Kiat H, Kavanagh PB, Moriel M, Mazzanti M, Su HT, et al. Automatic quantification of ejection fraction from gated myocardial perfusion SPECT. J Nucl Med. 1995;36:2138\u201347.","journal-title":"J Nucl Med"},{"key":"4068_CR20","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.ahj.2009.01.011","volume":"157","author":"FG Hage","year":"2009","unstructured":"Hage FG, Heo J, Franks B, Belardinelli L, Blackburn B, Wang W, et al. Differences in heart rate response to adenosine and regadenoson in patients with and without diabetes mellitus. Am Heart J. 2009;157:771\u20136. \n                    https:\/\/doi.org\/10.1016\/j.ahj.2009.01.011\n                    \n                  .","journal-title":"Am Heart J"},{"key":"4068_CR21","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1007\/s12350-015-0264-7","volume":"23","author":"S Bangalore","year":"2016","unstructured":"Bangalore S. Stress testing in patients with chronic kidney disease: the need for ancillary markers for effective risk stratification and prognosis. J Nucl Cardiol. 2016;23:570\u20134. \n                    https:\/\/doi.org\/10.1007\/s12350-015-0264-7\n                    \n                  .","journal-title":"J Nucl Cardiol"},{"key":"4068_CR22","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s12350-014-0006-2","volume":"22","author":"DV Rizk","year":"2015","unstructured":"Rizk DV, Riad S, Hage FG. Screening for coronary artery disease in kidney transplant candidates. J Nucl Cardiol. 2015;22:297\u2013300. \n                    https:\/\/doi.org\/10.1007\/s12350-014-0006-2\n                    \n                  .","journal-title":"J Nucl Cardiol"},{"key":"4068_CR23","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1007\/s12350-014-0051-x","volume":"22","author":"WL Duvall","year":"2015","unstructured":"Duvall WL, Rai M, Ahlberg AW, O'Sullivan DM, Henzlova MJ. A multi-center assessment of the temporal trends in myocardial perfusion imaging. J Nucl Cardiol. 2015;22:539\u201351. \n                    https:\/\/doi.org\/10.1007\/s12350-014-0051-x\n                    \n                  .","journal-title":"J Nucl Cardiol"},{"key":"4068_CR24","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1016\/j.jacc.2012.12.009","volume":"61","author":"AE Iskandrian","year":"2013","unstructured":"Iskandrian AE, Hage FG. Declining frequency of ischemia detection using stress myocardial perfusion imaging. J Am Coll Cardiol. 2013;61:1066\u20138. \n                    https:\/\/doi.org\/10.1016\/j.jacc.2012.12.009.","journal-title":"J Am Coll Cardiol"},{"key":"4068_CR25","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/j.jacc.2012.11.056","volume":"61","author":"A Rozanski","year":"2013","unstructured":"Rozanski A, Gransar H, Hayes SW, Min J, Friedman JD, Thomson LE, et al. Temporal trends in the frequency of inducible myocardial ischemia during cardiac stress testing: 1991 to 2009. J Am Coll Cardiol. 2013;61:1054\u201365. \n                    https:\/\/doi.org\/10.1016\/j.jacc.2012.11.056.","journal-title":"J Am Coll Cardiol"},{"key":"4068_CR26","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1007\/s12350-016-0441-3","volume":"23","author":"NS Bajaj","year":"2016","unstructured":"Bajaj NS, Singh S, Farag A, El-Hajj S, Heo J, Iskandrian AE, et al. The prognostic value of non-perfusion variables obtained during vasodilator stress myocardial perfusion imaging. J Nucl Cardiol. 2016;23:390\u2013413. \n                    https:\/\/doi.org\/10.1007\/s12350-016-0441-3\n                    \n                  .","journal-title":"J Nucl Cardiol"},{"key":"4068_CR27","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/0140-6736(92)93010-K","volume":"340","author":"CL Manske","year":"1992","unstructured":"Manske CL, Wang Y, Rector T, Wilson RF, White CW. Coronary revascularisation in insulin-dependent diabetic patients with chronic renal failure. Lancet. 1992;340:998\u20131002.","journal-title":"Lancet"},{"key":"4068_CR28","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.1056\/NEJMoa0805796","volume":"360","author":"RL Frye","year":"2009","unstructured":"Group BDS, Frye RL, August P, Brooks MM, Hardison RM, Kelsey SF, et al. A randomized trial of therapies for type 2 diabetes and coronary artery disease. N Engl J Med. 2009;360:2503\u201315. \n                    https:\/\/doi.org\/10.1056\/NEJMoa0805796.","journal-title":"N Engl J Med"},{"key":"4068_CR29","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1056\/NEJMoa070829","volume":"356","author":"WE Boden","year":"2007","unstructured":"Boden WE, O'Rourke RA, Teo KK, Hartigan PM, Maron DJ, Kostuk WJ, et al. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med. 2007;356:1503\u201316. \n                    https:\/\/doi.org\/10.1056\/NEJMoa070829\n                    \n                  .","journal-title":"N Engl J Med"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00259-018-4068-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-018-4068-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-018-4068-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,6]],"date-time":"2019-06-06T19:05:24Z","timestamp":1559847924000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00259-018-4068-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,7]]},"references-count":29,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["4068"],"URL":"https:\/\/doi.org\/10.1007\/s00259-018-4068-2","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,7]]},"assertion":[{"value":"9 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Drs. Hage and Iskandrian have received research grants from Astellas Pharma USA. All other authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. For this type of study formal consent is not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}